Ryuichi Nishii Selected Research

benzofuran

5/2018	18F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man 18F-FPYBF-2 PET imaging.
4/2018	18F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementia.
4/2011	Novel 18F-labeled benzofuran derivatives with improved properties for positron emission tomography (PET) imaging of β-amyloid plaques in Alzheimer's brains.
10/2010	A novel 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains.
10/2010	Fluorinated Benzofuran Derivatives for PET Imaging of β-Amyloid Plaques in Alzheimer's Disease Brains.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryuichi Nishii Research Topics

Disease

26	Neoplasms (Cancer) 10/2022 - 05/2004
8	Breast Neoplasms (Breast Cancer) 03/2021 - 04/2014
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 12/2008
5	Amyloid Plaque 05/2018 - 10/2010
4	Carcinoma (Carcinomatosis) 03/2021 - 04/2017
4	Melanoma (Melanoma, Malignant) 11/2020 - 06/2015
3	Atherosclerosis 10/2021 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 11/2018 - 10/2010
3	Prostatic Neoplasms (Prostate Cancer) 10/2016 - 05/2011
3	Seizures (Absence Seizure) 01/2013 - 01/2010
2	Bacterial Infections (Bacterial Infection) 05/2022 - 02/2022
2	Lung Neoplasms (Lung Cancer) 06/2020 - 05/2008
2	Lymphoma (Lymphomas) 11/2018 - 01/2018
2	Hypoxia (Hypoxemia) 11/2018 - 04/2009
2	Hypothyroidism 01/2018 - 09/2004
2	Brain Neoplasms (Brain Tumor) 01/2018 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2018 - 05/2011
2	Experimental Melanoma 01/2018 - 06/2015
2	Glioma (Gliomas) 01/2017 - 04/2009
2	Stroke (Strokes) 08/2012 - 03/2011
2	Infarction (Infarctions) 03/2011 - 12/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2006 - 02/2002
1	Infections 02/2022
1	Colitis 12/2021
1	Radiation Pneumonitis 01/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2020
1	Neuroblastoma 11/2020
1	Necrosis 05/2020

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 10/2021 - 04/2006
10	Amino Acids FDA Link 02/2022 - 05/2004
5	ErbB Receptors (EGF Receptor)IBA 10/2022 - 01/2014
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2022 - 05/2009
5	3-Iodobenzylguanidine (Iobenguane)IBA 12/2021 - 02/2002
5	Multidrug Resistance-Associated ProteinsIBA 03/2021 - 11/2018
5	benzofuranIBA 05/2018 - 10/2010
4	Tyrosine Kinase InhibitorsIBA 10/2022 - 04/2017
4	AcidsIBA 05/2022 - 05/2011
4	Biological ProductsIBA 02/2022 - 01/2018
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2021 - 11/2018
4	Adenosine Triphosphate (ATP)IBA 11/2020 - 04/2014
4	Amyloid (Amyloid Fibrils)IBA 11/2018 - 11/2011
4	Methionine (L-Methionine)FDA Link 01/2018 - 11/2012
3	Probenecid (Benemid)FDA LinkGeneric 03/2021 - 11/2007
3	Organic Anion TransportersIBA 03/2021 - 11/2007
3	verlukastIBA 11/2020 - 11/2018
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 05/2020 - 04/2014
3	EnzymesIBA 01/2018 - 03/2009
3	2,2-dimethyl-beta-alanineIBA 01/2018 - 10/2016
3	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 11/2007
3	Oxygen (Dioxygen)IBA 09/2015 - 12/2009
3	GABA-A Receptors (GABA(A) Receptor)IBA 01/2012 - 12/2009
2	RadiopharmaceuticalsIBA 05/2022 - 01/2018
2	Radioisotopes (Radionuclides)IBA 02/2022 - 06/2017
2	CholesterolIBA 10/2021 - 02/2002
2	CationsIBA 03/2021 - 11/2020
2	Peptides (Polypeptides)IBA 11/2020 - 01/2019
2	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 04/2014
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 11/2018 - 04/2018
2	ThymidineIBA 01/2018 - 06/2015
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018 - 05/2011
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2018 - 06/2015
2	Phenylthiourea (Phenylthiocarbamide)IBA 01/2018 - 06/2015
2	Melanins (Melanin)IBA 01/2018 - 06/2015
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2018 - 06/2015
2	Acetates (Acetic Acid Esters)FDA Link 01/2018 - 01/2013
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 06/2017 - 05/2011
2	Small Interfering RNA (siRNA)IBA 01/2013 - 05/2011
2	Flumazenil (Romazicon)FDA LinkGeneric 01/2012 - 01/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009 - 11/2006
1	osimertinibIBA 10/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2022
1	Dextrans (Dextran)FDA Link 12/2021
1	Cimetidine (Biomet)FDA LinkGeneric 12/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 12/2021
1	Molecular Probes (Molecular Probe)IBA 03/2021
1	Technetium Tc 99m Dimercaptosuccinic AcidIBA 03/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 03/2021
1	DNA (Deoxyribonucleic Acid)IBA 02/2021
1	Carbon-11IBA 02/2021
1	AnionsIBA 11/2020
1	multidrug resistance-associated protein 1IBA 11/2020
1	sodium-bile acid cotransporterIBA 11/2020
1	Inosine Monophosphate (IMP)IBA 11/2020
1	rociletinibIBA 06/2020
1	Technetium Tc 99m Mertiatide FDA Link 05/2020
1	NucleosidesIBA 11/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 10/2019
1	pitavastatin (itavastatin)FDA Link 10/2019
1	LigandsIBA 01/2019
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2019
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2019
1	Carboxylic AcidsIBA 01/2019
1	Type 1 Melanocortin ReceptorIBA 01/2019
1	quinolineIBA 01/2019
1	2-methoxyisobutylisonitrile (RP 30)IBA 11/2018
1	technetium tc-99m tetrofosmin (Myoview)FDA Link 11/2018
1	Verapamil (Calan)FDA LinkGeneric 11/2018

Therapy/Procedure

10	Therapeutics 11/2018 - 02/2002
2	Thyroidectomy 05/2011 - 09/2004
1	Heavy Ion Radiotherapy 01/2021